What are the products of GSK?
Consumer healthcare products
- Abreva (Docosanol)
- Advil (Ibuprofen)
- alli (Orlistat)
- Aquafresh (oral healthcare)
- Astring-o-Sol (oral healthcare)
- Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
- Binaca (oral healthcare)
- Biotene (oral healthcare)
Who is GSK’s biggest competitor?
GSK’s top competitors include AstraZeneca, Eli Lilly, Johnson & Johnson, Merck, Takeda Pharmaceutical, Roche and Bayer. GSK (GlaxoSmithKline) is a science-led healthcare company.
Who is owner of Glaxo?
GlaxoSmithKline Pharmaceuticals Ltd (BSE: 500660 NSE: GSKCONS) is an Indian subsidiary of GlaxoSmithKline plc, one of the world’s leading research based pharmaceutical and healthcare companies….GlaxoSmithKline Pharmaceuticals Ltd.
| Type | Public company |
|---|---|
| Parent | GlaxoSmithKline Plc |
| Website | www.gsk-india.com |
How many employees work at GSK?
Compare GSK With Other Stocks
| GlaxoSmithKline Annual Number of Employees | |
|---|---|
| 2020 | 94,066 |
| 2019 | 99,437 |
| 2018 | 95,490 |
| 2017 | 99,349 |
Is GlaxoSmithKline a good company to work for?
Since 2010, GlaxoSmithKline has several times ranked first among pharmaceutical companies on the Global Access to Medicines Index, which is funded by the Bill and Melinda Gates Foundation. In 2014 the Human Rights Campaign, an LGBT-rights advocacy group gave GSK a score of 100 percent in its Corporate Equality Index.
What are the research areas and products of GSK?
Research areas and products 1 Pharmaceuticals. GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes and mental health. 2 Malaria vaccine. In 2014, GSK applied for regulatory approval for the first malaria vaccine. 3 Consumer healthcare. 4 COVID-19 vaccine.
What is GlaxoSmithKline’s market capitalisation?
GlaxoSmithKline. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of August 2016 it had a market capitalisation of £81 billion (around $107 billion), the fourth largest on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange .
What does GSK’s split mean for Consumer Healthcare?
The culmination of the Consumer Healthcare string of deals will result in GSK splitting into two separate, via a demerger and subsequent listing of the joint venture, creating two publicly traded companies, one focusing on pharmaceuticals and research & development, the other on consumer healthcare.